SCRT

RADIATION9 trials

Conditions

CRC (Colorectal Cancer)Colorectal CancerLocally Advanced Rectal CancerPerennial Allergic RhinitisRadiationRectal CancerRectal Cancer, AdenocarcinomaToripalimab

Phase 2

The First-line Treatment of RCLM With RAS Mutation Was Local Short-course Radiotherapy (SCRT) + PD-1+ Standard Therapy

Not yet recruitingNCT05640726

Fujian Cancer HospitalRectal Cancer

Start: 2023-05-01End: 2026-05-01Target: 30Updated: 2022-12-07

SCRT Followed by Camrelizumab Combined With Fluzoparib and Chemotherapy as Neoadjuvant Therapy for LARC

RecruitingNCT06516445

Huazhong University of Science and TechnologyColorectal Cancer

Start: 2023-06-28End: 2026-06-28Target: 33Updated: 2024-07-24

Phase II RCT of LCRT vs SCRT + CAPOX/PD-1i/COX-2i in MSS Locally Advanced Rectal Cancer

RecruitingNCT07154316

Fudan UniversityColorectal Cancer

Start: 2025-08-01End: 2028-12-30Target: 138Updated: 2025-09-04

Efficacy and Safety of Retlirafusp Alfa Plus Bevacizumab and Chemotherapy With or Without Short-Course Radiotherapy in Patients With CRCLM

Not yet recruitingNCT07728019

Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyCRC (Colorectal Cancer)

Start: 2026-07-22End: 2031-12-31Target: 60Updated: 2026-07-27

Phase 3

Effect of Socheongryong-tang and Yeongyopaedok-san in Upper Respiratory Tract Infection

CompletedNCT01019889

Korea Health Industry Development InstituteUpper Respiratory Tract Infections

Start: 2008-09-30End: 2009-07-31Updated: 2012-04-06

Efficacy and Safety of So-Cheong-Ryong-Tang on Perennial Allergic Rhinitis

NCT03009136

Kyung Hee University Hospital at GangdongPerennial Allergic Rhinitis

Start: 2016-12-31End: 2018-12-31Target: 154Updated: 2017-03-14

TNT of SCRT+CAPOX vs SCRT+CAPOXIRI for Locally Advanced Rectal Cancer

RecruitingNCT05646511

National Cancer Center Hospital EastLocally Advanced Rectal Cancer

Start: 2022-11-21End: 2030-12-31Target: 608Updated: 2025-04-03

A Phase III Trial of Anus-preservation in Low Rectal Adenocarcinoma Based on MMR/MSI Status

NCT05669092

Zhejiang Cancer HospitalRadiation, Toripalimab

Start: 2022-11-01End: 2025-12-31Target: 174Updated: 2022-12-30

Unknown Phase

SCRT-NALIRIXELOX+Sintilimab as TNT for High-Risk LARC

RecruitingNCT07474103

Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyRectal Cancer, Adenocarcinoma

Start: 2025-11-30End: 2028-12-31Target: 49Updated: 2026-03-16

Related Papers

No operation after short-course radiotherapy followed by consolidation chemotherapy in locally advanced rectal cancer (NOAHS-ARC): study protocol for a prospective, phase II trial.

2025-03-181 citations

Protocol amendment for ENSEMBLE study: A multicenter, randomized, phase III trial to test the superiority of consolidation irinotecan, capecitabine and oxaliplatin vs capecitabine and oxaliplatin following short course radiotherapy as total neoadjuvant therapy in patients with locally advanced rectal cancer—Changing the irinotecan dosage.

Journal of Clinical Oncology2024-08-101 citations

A prospective multicenter phase II trial of total neoadjuvant therapy for locally advanced rectal cancer in JAPAN: ENSEMBLE-1 study.

Journal of Clinical Oncology2024-01-20

Anus preservation in low rectal adenocarcinoma based on MMR/MSI status (APRAM): a study protocol for a randomised, controlled, open-label, multicentre phase III trial.

2024-01-104 citations

Efficacy and safety of So-Cheong-Ryong-Tang in treatment of perennial allergic rhinitis: study protocol for a double-blind, randomised, parallel-group, multicentre trial

BMJ Open2017-09-019 citations